Equity Incentive Plans
2012 Stock Plan

Under our Amended and Restated 2012 Stock Plan (the “Plan”), we may grant incentive and nonqualified stock options, restricted stock, and restricted stock units (“RSUs”) to employees, officers, directors, and consultants. As of June 30, 2025, the maximum number of shares of common stock which may be issued under the Plan is 176,604,160 Class A shares and there were 53,851,610 shares of Class A common stock available for future grants under the Plan.

Stock Options

For stock options granted before our IPO in January 2021, the minimum expiration period is seven years after termination of employment or 10 years from the date of grant. For stock options granted after our IPO, the minimum expiration period is three months after termination of employment or 10 years from the date of grant. Stock options generally vest over a period of four years or with 25% vesting on the 12 month anniversary of the vesting commencement date, and the remainder vesting on a pro-rata basis each month over the next three years.

The following table summarizes our stock option activity for the year ended June 30, 2025:
Number of OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value (in thousands)
Balance as of June 30, 202416,794,697 $15.84 5.63
Granted677,433 44.66 
Exercised(4,484,133)10.56 
Forfeited, expired or canceled(32,019)34.21 
Balance as of June 30, 202512,955,978 19.12 5.18
Vested and exercisable, June 30, 202510,615,703 $16.81 4.51$557,041 
Vested and exercisable, and expected to vest thereafter (1) June 30, 2025
12,914,059 $19.06 5.16$648,399 
(1)Options expected to vest reflect the application of an estimated forfeiture rate.

The weighted-average grant date fair value of options granted for the years ended June 30, 2025, 2024, and 2023, was $31.74, $16.37, and $10.92, respectively. The aggregate intrinsic value of options exercised was approximately $234.5 million, $79.0 million, and $12.6 million for the years ended June 30, 2025, 2024, and 2023, respectively. The total fair value of stock options vested during the years ended June 30, 2025, 2024, and 2023 was $26.8 million, $24.3 million, and $39.5 million, respectively.
The fair value of each option on the date of grant is determined using the Black Scholes-Merton option pricing model using the single-option award approach with the weighted-average assumptions set forth in the table below. Volatility is based on historical volatility rates obtained from certain public companies that operate in the same or related business as us since there is a limited period of historical market data for our common stock. The risk-free interest rate is determined using a U.S. Treasury rate for the period that coincides with the expected term set forth. We used the simplified method to determine an estimate of the expected term of an employee share option.

June 30, 2025June 30, 2024June 30, 2023
Volatility80%75%59%
Risk-free interest rate
3.46% - 4.35%
4.21% - 4.36%
2.88% - 3.87%
Expected term (in years)6.066.056.04
Expected dividend yield

As of June 30, 2025, unrecognized compensation expense related to unvested stock options was approximately $39.4 million, which is expected to be recognized over a remaining weighted-average period of 2.2 years.

Value Creation Award

In November 2020, the Companys Board of Directors approved a long-term, multi-year performance-based stock option grant providing Mr. Levchin with the opportunity to earn the right to purchase up to 12,500,000 shares of the Companys Class A common stock (the “Value Creation Award”).

As discussed below, the Value Creation Award will only be earned, if at all, in the event the price of our Class A common stock attains stock price hurdles that are significantly in excess of the Company's IPO price per share, over a period of five years, subject to Mr. Levchin’s continued service to the Company.

The Value Creation Award is divided into ten tranches, each of which Mr. Levchin may earn by satisfying a performance condition within a five-year period following the IPO. The performance condition for each tranche will be satisfied on the date the 90 average trading day volume weighted share price of the Company’s Class A common stock exceeds certain specified stock price hurdles, presented in the table below, which were determined based on a target percentage of share price appreciation from the IPO price. Once earned as a result of satisfying the performance condition, the options will vest and become exercisable over a five-year period that commenced at the time of the IPO, subject to Mr. Levchin’s continued service to the Company, in annual amounts equal to 15%, 15%, 20%, 25% and 25%, respectively. The per share exercise price of the Value Creation Award is $49.00, the price to the public in the IPO.
TrancheStock Price HurdleNumber of Options
1$65.66 1,000,000 
2$82.32 1,000,000 
3$98.98 1,000,000 
4$115.64 1,000,000 
5$132.30 1,000,000 
6$148.47 1,000,000 
7$165.13 1,000,000 
8$181.79 1,000,000 
9$247.94 2,250,000 
10$371.91 2,250,000 
Total12,500,000 

We recognize stock-based compensation on these awards based on the grant date fair value using an accelerated attribution method over the requisite service period, and only if performance-based conditions are considered probable of being satisfied. During the years ended June 30, 2025, 2024, and 2023, we incurred stock-based compensation expense of $36.5 million, $64.6 million, and $94.6 million, respectively, associated with the Value Creation Award as a component of general and administrative expense within the consolidated statements of operations and comprehensive income (loss). As of the beginning of the 12 month period ended June 30, 2025, 4,000,000 shares had vested based on conditions met in prior periods. No additional shares vested during the year ended June 30, 2025. As of June 30, 2025, none of these awards have been exercised.

As of June 30, 2025, unrecognized compensation expense related to the Value Creation Award was approximately $11.8 million, which is expected to be recognized over a remaining weighted-average period of 0.5 years.

Restricted Stock Units

RSUs granted prior to the IPO were subject to two vesting conditions: a service-based vesting condition (i.e., employment over a period of time) and a performance-based vesting condition (i.e., a liquidity event in the form of either a change of control or an initial public offering, each as defined in the Plan), both of which must be met in order to vest. The performance-based condition was met upon the IPO. We record stock-based compensation expense for those RSUs on an accelerated attribution method over the requisite service period, which is generally four years. RSUs granted after IPO are subject to a service-based vesting condition. We record stock-based compensation expense for service-based RSUs on a straight-line basis over the requisite service period, which is generally one to four years.

The following table summarizes our RSU activity during the year ended June 30, 2025:
Number of SharesWeighted Average Grant Date Fair Value
Non-vested at June 30, 202418,327,420 $27.68 
Granted12,038,819 34.59 
Vested(14,517,850)30.18 
Forfeited, expired or canceled(2,182,354)28.48 
Non-vested at June 30, 202513,666,035 $30.98 
As of June 30, 2025, unrecognized compensation expense related to unvested RSUs was approximately $394.1 million, which is expected to be recognized over a remaining weighted-average period of 1.5 years.

2020 Employee Stock Purchase Plan

On November 18, 2020, our Board of Directors adopted and approved the 2020 Employee Stock Purchase Plan (“ESPP”). The purpose of the ESPP is to secure the services of new employees, to retain the services of existing employees and to provide incentives for such individuals to exert maximum effort towards the success of the Company and that of its affiliates. A total of 16.0 million shares of Class A common stock are reserved and available for issuance under the ESPP and 2.1 million shares have been issued as of June 30, 2025. The ESPP provides for six-month offering periods beginning December 1 and June 1 of each year. At the end of each offering period, shares of our Class A common stock are purchased on behalf of each ESPP participant at a price per share equal to 85% of the lesser of (1) the fair market value of the Class A common stock on first day of the offering period (the grant date) or (2) the fair market value of the Class A common stock on the last day of the offering period (the purchase date). We use the Black-Scholes-Merton option pricing model to measure the fair value of the purchase rights issued under the ESPP at the first day of the offering period, which represents the grant date. We record stock-based compensation expense on a straight-line basis over each six-month offering period, the requisite service period of the award.

Stock-Based Compensation Expense

The following table presents the components and classification of stock-based compensation (in thousands):
June 30, 2025June 30, 2024June 30, 2023
General and administrative$216,323 $228,334 $239,923 
Technology and data analytics87,707 96,596 181,396 
Sales and marketing16,535 16,374 25,914 
Processing and servicing868 3,207 4,476 
Total stock-based compensation in operating expenses321,433 344,511 451,709 
Capitalized into property, equipment and software, net178,461 126,510 80,108 
Total stock-based compensation$499,894 $471,021 $531,817 

Historical Timeline

Fiscal YearFiled
2025Aug 28, 2025Showing above
2024Aug 28, 2024
2023Aug 25, 2023
2022Aug 29, 2022

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.